Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Research Corp (NASDAQ:ARWR)

5.47
Delayed Data
As of 1:21pm ET
 -0.36 / -6.17%
Today’s Change
4.35
Today|||52-Week Range
17.42
-25.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$346.9M

Company Description

Arrowhead Research Corp. is a biopharmaceutical company developing targeted RNAi therapeutics. It is leveraging its proprietary drug delivery technologies to develop drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Research Corp.
225 South Lake Avenue
Pasadena California 91101-3009
P:(626) 304-3400
Investor Relations:

Employees

Shareholders

Other institutional28.59%
Individual stakeholders2.09%
Mutual fund holders17.54%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Bruce D. GivenChief Operating Officer
Kenneth Allen MyszkowskiChief Financial Officer
David LewisChief Scientific Officer
Jane DavidsonSecretary & Vice President-Administration